5th Annual Digestive Diseases : New Advances Conference
In-Person Event
Mar 16 - 17, 2018
Philadelphia, Pennsylvania, USA
OVERVIEW
5th Annual Digestive Diseases : New Advances Conference is organized by Global Academy for Medical Education and will be held during Mar 16 - 17, 2018 at The Westin Philadelphia, Philadelphia, Pennsylvania, United States of America.
The target audience for this medical event is Gastroenterologists. This CME Conference has been approved for a maximum of 13.00 AMA PRA Category 1 Credits.
Conference Description :
The complexity and magnitude of medical advances in the management of digestive diseases make it ever more challenging for clinicians to apply this tremendous amount of information to their practice.
This activity will provide learners with a comprehensive overview of the state-of-the art advances in the diagnostic, therapeutic, and preventive modalities of digestive diseases based on the latest evidence, literature, and clinical research. A thorough review of the current treatment landscape is vital to both clinicians and patients who can benefit from the expansion of therapeutic options.
Conference Objectives are :
• Outline the pathogenesis, diagnosis and treatment of eosinophilic esophagitis.
• Discuss the risk-benefit ratio of proton pump inhibitors (PPIs).
• Recognize the manifestations of celiac disease and use appropriate tests to identify the disease.
• Apply a multidisciplinary approach to the treatment of celiac disease. Compare treatment options available for the management of gastroparesis.
• Identify barriers to colorectal cancer screening and utilize appropriate strategies to identify and address these barriers.
• Differentiate irritable bowel syndrome (IBS) from other common gastrointestinal disorders.
• Describe new and emerging management strategies for IBS.
• Review the most current perspectives and clinical guidelines for the management of inflammatory bowel disease (IBD).
• Incorporate a treatment approach for those patients with IBD that are difficult to treat. • Assess optimal management strategies for patients with hepatic encephalopathy.
• Outline the diagnosis and treatment strategies for patients with hepatitis B.
• Evaluate the efficacy and safety of current and emerging therapeutic strategies for the treatment of hepatitis C virus (HCV).
• Describe the recent advances in the management of hepatocellular carcinoma....
The target audience for this medical event is Gastroenterologists. This CME Conference has been approved for a maximum of 13.00 AMA PRA Category 1 Credits.
Conference Description :
The complexity and magnitude of medical advances in the management of digestive diseases make it ever more challenging for clinicians to apply this tremendous amount of information to their practice.
This activity will provide learners with a comprehensive overview of the state-of-the art advances in the diagnostic, therapeutic, and preventive modalities of digestive diseases based on the latest evidence, literature, and clinical research. A thorough review of the current treatment landscape is vital to both clinicians and patients who can benefit from the expansion of therapeutic options.
Conference Objectives are :
• Outline the pathogenesis, diagnosis and treatment of eosinophilic esophagitis.
• Discuss the risk-benefit ratio of proton pump inhibitors (PPIs).
• Recognize the manifestations of celiac disease and use appropriate tests to identify the disease.
• Apply a multidisciplinary approach to the treatment of celiac disease. Compare treatment options available for the management of gastroparesis.
• Identify barriers to colorectal cancer screening and utilize appropriate strategies to identify and address these barriers.
• Differentiate irritable bowel syndrome (IBS) from other common gastrointestinal disorders.
• Describe new and emerging management strategies for IBS.
• Review the most current perspectives and clinical guidelines for the management of inflammatory bowel disease (IBD).
• Incorporate a treatment approach for those patients with IBD that are difficult to treat. • Assess optimal management strategies for patients with hepatic encephalopathy.
• Outline the diagnosis and treatment strategies for patients with hepatitis B.
• Evaluate the efficacy and safety of current and emerging therapeutic strategies for the treatment of hepatitis C virus (HCV).
• Describe the recent advances in the management of hepatocellular carcinoma....
KEY DATES
16 Mar, 2018
Event Start Date
17 Mar, 2018
Event End Date
SPECIALITIES
GastroenterologySUGGESTED HOTELS
CONFERENCE VENUE
The Westin PhiladelphiaRELATED CONFERENCES & LIVE WEBINARS
Quick Links